Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitorsKey points

by Eleonora De Martin, Jean-Marie Michot, Olivier Rosmorduc, Catherine Guettier, Didier Samuel
Published 2020-12-01

Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation?

by Selma Addou, Clémentine Sarkozy, Julien Lazarovici, Stéphane Champiat, Aspasia Stamatoullas, Fabrice Jardin, Vincent Ribrag, Aurélien Marabelle, Jean-Marie Michot
Published 2021-10-01

Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit

by Adrien Joseph, Audrey Simonaggio, Annabelle Stoclin, Antoine Vieillard-Baron, Guillaume Geri, Stéphane Oudard, Jean-Marie Michot, Olivier Lambotte, Elie Azoulay, Virginie Lemiale
Published 2020-10-01

Successful Outcome of a Corticodependent Henoch-Schönlein Purpura Adult with Rituximab

by Taylor Pindi Sala, Jean-Marie Michot, Renaud Snanoudj, Marion Dollat, Emmanuel Estève, Bernadette Marie, Yacine Taoufik, Jean-François Delfraissy, Thierry Lazure, Olivier Lambotte
Published 2014-01-01

Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study

by Fabio Andreozzi, Matteo Dragani, Cyril Quivoron, Fabien Le Bras, Tarek Assi, Alina Danu, Karim Belhadj, Julien Lazarovici, Sophie Cotteret, Olivier A. Bernard, Vincent Ribrag, Jean-Marie Michot
Published 2023-02-01

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.

by Laurent Alric, Caroline Besson, Nathanael Lapidus, Juliette Jeannel, Jean-Marie Michot, Patrice Cacoub, Danielle Canioni, Stanislas Pol, Frédéric Davi, Pascaline Rabiega, Loic Ysebaert, Delphine Bonnet, Olivier Hermine
Published 2016-01-01

CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy

by Jean-Marie Michot, Severine Mouraud, Julien Adam, Julien Lazarovici, Camille Bigenwald, Charlotte Rigaud, Lambros Tselikas, Peggy Dartigues, Alina Danu, Amélie Bigorgne, Veronique Minard, David Ghez, Aurélien Marabelle, Laurence Zitvogel, Vincent Ribrag
Published 2021-10-01

Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types

by Patricia Martin‐Romano, Eduardo Castanon, Samy Ammari, Stéphane Champiat, Antoine Hollebecque, Sophie Postel‐Vinay, Capucine Baldini, Andrea Varga, Jean Marie Michot, Perrine Vuagnat, Aurélien Marabelle, Jean‐Charles Soria, Charles Ferté, Christophe Massard
Published 2020-04-01

Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score

by Monica Pierro, Capucine Baldini, Edouard Auclin, Hélène Vincent, Andreea Varga, Patricia Martin Romano, Perrine Vuagnat, Benjamin Besse, David Planchard, Antoine Hollebecque, Stéphane Champiat, Aurélien Marabelle, Jean-Marie Michot, Christophe Massard, Laura Mezquita
Published 2022-10-01

Repeated courses of low‐dose 2 × 2 Gy radiation therapy in patients with indolent B‐cell non‐Hodgkin lymphomas

by Khalil Saleh, Jean‐Marie Michot, Antoine Schernberg, Julien Lazarovici, Claude Chahine, Alina Danu, Nadine Khalife‐Saleh, Julien Rossignol, David Ghez, Valentine Martin, Renaud Mazeron, Christophe Fermé, Angela Boros, Vincent Ribrag, Theodore Girinsky
Published 2020-06-01

Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case report

by Mihaela Aldea, Rakiba Belkhir, Emeline Colomba, Pierre Blanchard, Francois-Xavier Danlos, Angela Botticella, Mario Terlizzi, Eric Deutsch, Eric Deutsch, Cecile Le Péchoux, David Planchard, Jean-Marie Michot, Benjamin Besse, Antonin Levy, Antonin Levy
Published 2022-10-01

Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma

by Cyril Quivoron, Anthony Tarabay, Jean-Marie Michot, Arnaud Pagès, Hélène Lecourt, Anne Aupérin, Alina Danu, Julien Lazarovici, Julien Rossignol, David Ghez, Peggy Dartigues, Véronique Vergé, Christophe Massard, Valérie Camara-Clayette, Vincent Ribrag, Clémentine Sarkozy
Published 2022-03-01

Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

by María Victoria Mateos, Felipe Prosper, Jesús Martin Sánchez, Enrique M. Ocio, Albert Oriol, Cristina Motlló, Jean‐Marie Michot, Isidro Jarque, Rebeca Iglesias, María Solé, Sara Martínez, Carmen Kahatt, Salvador Fudio, Gema Corral, Ali Zeaiter, Lola Montilla, Vincent Ribrag
Published 2023-02-01

When monoclonal gammopathy‐associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes

by Christophe Willekens, Claude Chahine, Matteo Dragani, Sabine Khalife‐Hachem, Camille Bigenwald, Julien Rossignol, Cristina Castilla‐Llorente, Alina Danu, Jean‐Marie Michot, Veronique Saada, Sophie Cotteret, Christophe Marzac, Aline Renneville, Isabelle Plo, Sophie Broutin, Nelly Bosselut, Bruno Cassinat, Julien Lazarovici, Nathalie Droin, Stephane De Botton
Published 2023-08-01

A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

by Mehdi Khellaf, Jean-François Viallard, Mohamed Hamidou, Stéphane Cheze, Françoise Roudot-Thoraval, François Lefrere, Olivier Fain, Sylvain Audia, Jean-François Abgrall, Jean-Marie Michot, Charles Dauriac, Sophie Lefort, Emmanuel Gyan, Mathilde Niault, Jean-Marc Durand, Laetitia Languille, David Boutboul, Philippe Bierling, Marc Michel, Bertrand Godeau
Published 2013-06-01

BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas

by Victor Moreno, Maria Vieito, Juan Manuel Sepulveda, Vladimir Galvao, Tatiana Hernández-Guerrero, Bernard Doger, Omar Saavedra, Carmelo Carlo-Stella, Jean-Marie Michot, Antoine Italiano, Massimo Magagnoli, Cecilia Carpio, Antonio Pinto, Rafael Sarmiento, Barbara Amoroso, Ida Aronchik, Ellen Filvaroff, Bishoy Hanna, Xin Wei, Zariana Nikolova, Irene Braña
Published 2023-03-01

Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series

by Isabelle Serre, Olivier Lambotte, Stephane Ederhy, Jean-Marie Michot, Jean-Luc Faillie, Alexandre Thibault Jacques Maria, Xavier Quantin, Candice Lesage, Patricia Rullier, Philippe Guilpain, Romaric Larcher, Kada Klouche, Gerald Chanques, Mathieu Puyade, François Roubille, Nahéma Issa, Olivier Dereure, Cyrille Coustal, Juliette Vanoverschelde, Ariane Lappara, Eric Assenat, Maxime Faure, Diego Tosi, Hélène Vernhet-Kovacsik, Audrey Agullo
Published 2023-05-01

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.

by Danielle Canioni, Jean-Marie Michot, Pascaline Rabiega, Thierry J Molina, Frédéric Charlotte, Thierry Lazure, Frédéric Davi, Catherine Settegrana, Françoise Berger, Laurent Alric, Patrice Cacoub, Benjamin Terrier, Felipe Suarez, David Sibon, Jehan Dupuis, Cyrille Feray, Hervé Tilly, Stanislas Pol, Bénédicte Deau Fischer, Sandrine Roulland, Catherine Thieblemont, Véronique Leblond, Fabrice Carrat, Olivier Hermine, Caroline Besson, national ANRS HC13 LymphoC study
Published 2016-01-01

S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA

by Amira Marouf, Sammara Chaubard, Jean Marie Michot, Julien Rossignol, Camille Golfier, Olivier Allangba, Laure Philippe, Benoit Tessoulin, Adrien Chauchet, Bénédicte Deau, Lucie Oberic, Jacques Vargaftig, Aline Moignet, Aline Clavert, Rémy Duléry, Gabriel Brisou, Stéphanie Tardy, Virginie Fataccioli, Roch Houot, Rene Olivier Casasnovas, Catherine Thieblemont, Herve Ghesquieres, Sylvain Carras, Steven Le Gouill, Guillaume Cartron, Aurélien Marabelle, Olivier Tournilhac, Gandhi Laurent Damaj, Philippe Gaulard, Laurence De Leval, Francois Lemonnier, Emmanuel Bachy, Olivier Hermine, Lucile Couronné, Arnaud Jaccard
Published 2023-08-01

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

by Guillaume Manson, Alexandre Thibault Jacques Maria, Florence Poizeau, François-Xavier Danlos, Marie Kostine, Solenn Brosseau, Sandrine Aspeslagh, Pauline Du Rusquec, Maxime Roger, Maud Pallix-Guyot, Marc Ruivard, Léa Dousset, Laurianne Grignou, Dimitri Psimaras, Johan Pluvy, Gilles Quéré, Franck Grados, Fanny Duval, Frederic Bourdain, Gwenola Maigne, Julie Perrin, Benoit Godbert, Beatris Irina Taifas, Alexandra Forestier, Anne-Laure Voisin, Patricia Martin-Romano, Capucine Baldini, Aurélien Marabelle, Christophe Massard, Jérôme Honnorat, Olivier Lambotte, Jean-Marie Michot
Published 2019-12-01